Sudarshan Chemical Industries Ltd
Sudarshan Chemical Industries Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
Guidance rank: #51 of 68 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
What the Q1 FY27 call signalled
1 of 3 strong
The short version
The company projects reaching Rs.12,000 Crores+ in revenue post-Heubach acquisition, indicating aggressive growth potential (Page 14). Sudarshan expects a revenue CAGR of 5% to 7% over the next 2-3 years, with a focus on profitable growth rather than aggressive topline expansion.
From Sudarshan Chemical Industries Ltd's Q1 FY27 earnings-call transcript · updated 27 Aug 2026.
Revenue & Sales Performance
- The company projects reaching Rs.12,000 Crores+ in revenue post-Heubach acquisition, indicating aggressive growth potential (Page 14).
- Growth is expected from recapturing lost business due to past integration challenges within Heubach (Page 14).
- Revenue growth is anticipated to be in high single digits to low double digits for the acquired group, not a uniform 15% (Page 13).
- Legacy Sudarshan business is expected to continue growing at around 12%-13% (Page 5).
- Management expects a revenue CAGR of 5%-7% over the next 2-3 years, split between volume and value growth driven by premiumization (Page 8).
- The company is focused on profitable growth, avoiding hampering gross margins, emphasizing value capture and cost efficiencies (Page 9).
2 more points from Sudarshan Chemical Industries Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Sudarshan Chemical Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- No substantial new capex is expected in the near term as current capacities are sufficient to support indicated growth.
- Moderate capex may be undertaken for special initiatives such as backward integration or new special projects.
- Any new investments will be driven by ROI considerations; only projects with good returns will be pursued.
2 more points from Sudarshan Chemical Industries Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Sudarshan Chemical Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Sudarshan Chemical Industries Ltd said on order book & pipeline — free account, 30 seconds.
Sudarshan Chemical Industries Ltd — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹2.8K Cr, net profit ₹82 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Sudarshan Chem.'s management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q2 FY26 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- Alufluoride (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
- POCL Enterprises (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Devson Catalyst (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Ambani Orgochem (Q1 FY27)
Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Sudarshan Chemical Industries Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Sudarshan Chemical Industries Ltd Q1 FY27 results?
The company projects reaching Rs.12,000 Crores+ in revenue post-Heubach acquisition, indicating aggressive growth potential (Page 14). Sudarshan expects a revenue CAGR of 5% to 7% over the next 2-3 years, with a focus on profitable growth rather than aggressive topline expansion.
What is Sudarshan Chemical Industries Ltd share price analysis?
Sudarshan Chemical Industries Ltd currently shows a below-average growth signal. The stock trades at a P/E of 95.2 with a market cap of ₹9,673 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sudarshan Chemical Industries Ltd planning capital expenditure?
No substantial new capex is expected in the near term as current capacities are sufficient to support indicated growth.
Keep Sudarshan Chemical Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.